首页> Multiple sclerosis and related disorders> Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis.

Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： J,Hillen

第一单位： Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Australia. Electronic address: jodie.hillen@unisa.edu.au.

作者： J,Hillen ^[1] ; M,Ward ^[2] ; M,Slee ^[3] ; T,Stanford ^[4] ; E,Roughead ^[4] ; L,Kalisch Ellett ^[4] ; N,Pratt ^[4]

作者单位： Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Australia. Electronic address: jodie.hillen@unisa.edu.au. ^[1] Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Australia; Pharmacy Education, Clinical and Health Sciences, University of South Australia, Australia. ^[2] College of Medicine and Public Health, Flinders University, Adelaide, Australia. ^[3] Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Australia. ^[4]

关键词 Drug utilisation study Mulitple Sclerosis Therapeutics Treatment Patterns

医学主题词成年人(Adult);澳大利亚(Australia);女(雌)性(Female);人类(Humans);男(雄)性(Male);多发性硬化(Multiple Sclerosis);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting)

DOI 10.1016/j.msard.2021.103412

PMID 34856498

发布时间 2022-02-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交